Expertise dedicated to facilitating and accelerating the delivery of image-driven ophthalmic innovations to the clinic.

Translational Imaging Innovations, Inc. (TII) was founded by Eric Buckland, Ph.D., co-founder and CEO of OCT innovator Bioptigen. TII was formed directly as a response to opportunity and challenges of translational imaging in ophthalmology observed during his Bioptigen tenure.

Eric Buckland, PhD

Eric Buckland, PhD


Rob Williams

Rob Williams, MBA


Micaela Mendlow

Micaela Mendlow, PhD

Computational scientist

Andrew Witchger

Andrew Witchger

Senior Engineer

Taylor Szeto

Taylor Szeto

Program Manager

Alex Salmon, PhD

Alex Salmon, PhD

software developer


Joseph Carroll, PhD

Chief Science Advisor

Brad Fortner, PhD

DATA Science Advisor

Rob Cooper, PhD

Biomarker Scientist

Brandon Lujan, MD

Chief Medical Advisor